← Leaderboards
Michael C Bassik
Stanford University
$11,228,510
Attributed
$20,241,839
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,241,839 · 8
By mechanism
R01$7,432,198 · 3
UM1$5,442,162 · 1
U01$3,153,893 · 1
DP2$2,407,500 · 1
U54$1,806,086 · 2
Top collaborators
- Eric Alejandro Sweet-Cordero10 shared
- Jennifer R Cochran5 shared
- William James Greenleaf5 shared
- Peter Kent Jackson5 shared
- Lacramioara Bintu4 shared
- Ami Siddharth Bhatt1 shared
Most similar at Stanford University
Same institution · by research overlap
- Hanlee Ji$24,780,644
- Calvin J Kuo$48,363,495
- Jonathan R Pollack$9,181,908
- Kenan Christopher Garcia$35,612,900
- Georgios Skiniotis$19,731,539
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesProteinsCrispr ScreenCellsSignal TransductionMalignant NeoplasmsLibrariesEngineeringPropertyTumorClustered Regularly Interspaced Short Palindromic RepeatsIn VivoGenome-WideGenomicsGeneticCell LineGenetic TranscriptionGene ExpressionGrowthMolecularProteomicsExperimental StudyMapsMediating
Grant awards (28)
Mining the microbiome for immunomodulatory microproteins$640,522
R01 · FY2025 · CA
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance$333,522
U54 · FY2025 · CA · contact PI
High-throughput development and characterization of compact tools for transcriptional and chromatin perturbations$972,736
R01 · FY2024 · HG
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance$335,096
U54 · FY2024 · CA · contact PI
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance$62,921
U54 · FY2024 · CA · contact PI
High-throughput development and characterization of compact tools for transcriptional and chromatin perturbations$992,590
R01 · FY2023 · HG
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance$345,678
U54 · FY2023 · CA · contact PI
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance$66,233
U54 · FY2023 · CA · contact PI
High-throughput development and characterization of compact tools for transcriptional and chromatin perturbations$992,642
R01 · FY2022 · HG
Development of novel protein-based therapeutics for lung cancer$552,581
R01 · FY2022 · CA
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance$399,288
U54 · FY2022 · CA · contact PI
High-throughput systematic characterization of regulatory element function$1,032,594
UM1 · FY2021 · HG
High-throughput development and characterization of compact tools for transcriptional and chromatin perturbations$992,388
R01 · FY2021 · HG
Development of novel protein-based therapeutics for lung cancer$563,856
R01 · FY2021 · CA
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance$263,348
U54 · FY2021 · CA · contact PI
High-throughput systematic characterization of regulatory element function$1,032,594
UM1 · FY2020 · HG
Development of novel protein-based therapeutics for lung cancer$563,401
R01 · FY2020 · CA
High-throughput systematic characterization of regulatory element function$1,032,594
UM1 · FY2019 · HG
Development of novel protein-based therapeutics for lung cancer$557,605
R01 · FY2019 · CA
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer$538,965
U01 · FY2019 · CA
High-throughput systematic characterization of regulatory element function$1,032,594
UM1 · FY2018 · HG
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer$623,508
U01 · FY2018 · CA
Development of novel protein-based therapeutics for lung cancer$603,877
R01 · FY2018 · CA
High-throughput systematic characterization of regulatory element function$1,311,786
UM1 · FY2017 · HG
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer$663,150
U01 · FY2017 · CA
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer$663,814
U01 · FY2016 · CA
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer$664,456
U01 · FY2015 · CA
Accelerating drug development and repurposing using systematic genetic interactio$2,407,500
DP2 · FY2014 · HD · contact PI